Ebola Research Begins at NEIDL
Eight months after receiving final approval from the Boston Public Health Commission to conduct research at Biosafety Level 4 (BSL-4), Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) has begun work with its first Level-4 pathogen, the Ebola virus. “This is clearly an important step for the NEIDL,” says Ronald B. Corley, NEIDL director and a School of […]
